SCHEMBL7015178

SCHEMBL7015178

Cc1ccc(-n2cccc2C=O)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.48
KMT2A Q03164 3/20 0.46
ATM Q13315 1/20 0.45
CYP1A2 P05177 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 6/20 0.42
TRIM24 O15164 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
METAP2 P50579 1/20 0.40
POLB P06746 2/20 0.38
CYP2A6 P11509 1/20 0.35
ALDH1A3 P47895 1/20 0.34
MAPT P10636 2/20 0.34
RAB9A P51151 2/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9043758 0.81 ALDH1A1 (0.49) GAAKMT2AATMCYP1A2L3MBTL1
SCHEMBL8322750 0.78 ATM (0.45) GAAKMT2AATMCYP1A2L3MBTL1
SCHEMBL8306979 0.74 METAP2 (0.48) GAAKMT2ACYP1A2ALDH1A1METAP2
SCHEMBL4543897 0.74 POLB (0.50) KMT2ACYP1A2L3MBTL1ALDH1A1METAP2
SCHEMBL3211700 0.73 ATM (0.69) GAAKMT2AATMCYP1A2L3MBTL1
SCHEMBL4669012 0.72 GAA (0.51) GAAKMT2AATMCYP1A2L3MBTL1
SCHEMBL7008935 0.72 KDM4E (0.38) GAAL3MBTL1ALDH1A1METAP2MAPT
SCHEMBL950321 0.72 ALDH1A1 (0.45) GAAKMT2AATMCYP1A2L3MBTL1
SCHEMBL9044926 0.72 PKM (0.60) GAAKMT2AATMCYP1A2L3MBTL1
SCHEMBL9043185 0.71 METAP2 (0.36) KMT2AALDH1A1METAP2CYP2A6ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1327631-A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists Takeda Chemical Industries, Ltd. (JP) 2003-07-16 EP disclosed
EP-0518033-B1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-07-02 EP disclosed
EP-0480204-B1 Imidazole derivatives, potent and selective antagonists of angiotensin II receptor FUJISAWA PHARMACEUTICAL CO (JP) 1996-03-20 EP disclosed
US-5389641-A Fused heterocyclic compounds, having angiotensin II antagonistic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-14 US disclosed
US-5215994-A Treating or preventing hypertension or heart failure FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-06-01 US disclosed
US-5210092-A Hypotensive agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-05-11 US disclosed
EP-0518033-A1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-16 EP disclosed
EP-0480204-A1 Imidazole derivatives, potent and selective antagonists of angiotensin II receptor FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed